Menu
Not yet recruiting NCT06771739

A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

No phase Interventional Malignant Solid Neoplasm

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Electronic Health Record Review, Interview, Support, Support.
Who it may be relevant to
Registry conditions: Malignant Solid Neoplasm. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Preventing Financial Adversity Among Early-Stage Cancer Patients Through Unrestricted Cash (PAYMENT) Pilot Study

Overview

This clinical trial studies whether an unrestricted cash payment program can be used to improve financial and clinical outcomes in early-stage cancer patients with financial concerns. A cancer diagnosis can have poor financial outcomes, and the cost of cancer treatment can lead to high medical debt and financial hardships for the patient and family. Financial hardship during cancer treatment is associated with adverse outcomes including poorer quality of life, lower treatment compliance, more aggressive use of hospital-based care, and worse survival. Newly diagnosed cancer patients with financial concerns may avoid treatment entirely so that they can continue to work and maintain income, provide for their families, or pay rent. An unrestricted cash payment program provides patients with a preloaded cash card once monthly. The patients can choose what to use the card to pay for and may include items like food, rent, or utilities. This provides a period of guaranteed income for the patients and may prevent them from falling into poverty and improve financial and clinical outcomes.

Detailed description

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM A: Patients receive a $1000 preloaded cash card once monthly for 3 months.

ARM B: Patients receive a $100 preloaded cash card once monthly for 3 months.

After completion of study intervention, patients are followed up 3 months and 6 months post randomization.

Interventions

  • Other Electronic Health Record Review
    Ancillary studies
  • Other Interview
    Ancillary studies
  • Other Support
    Receive $1000 preloaded cash card
  • Other Support
    Receive $100 preloaded cash card
  • Other Survey Administration
    Ancillary studies

Primary outcome measures

  • Participant enrollment [Time frame: Up to 1 year]
  • Time to accrue 20 patients [Time frame: Up to 1 year]
  • Dropout rate [Time frame: Up to 1 year]
  • Survey completion rate [Time frame: Up to 1 year]
Secondary outcome measures (5)
  • Financial hardship [Time frame: Baseline, 3 and 6- months post randomization]
  • Treatment nonadherence [Time frame: Baseline, 3 and 6- months post randomization]
  • Unplanned emergency department (ED)/hospital admissions [Time frame: Baseline, 3 and 6- months post randomization]
  • Food and housing insecurity [Time frame: Baseline, 3 and 6- months post randomization]
  • Quality of life [Time frame: Baseline, 3 and 6- months post randomization]

Eligibility criteria

Inclusion criteria

  • Age >= 18
  • Ability to understand English
  • Ability to understand and willingness to sign a written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants
  • Within 90 days of a non-metastatic or early-stage solid tumor receiving or rescheduled to receive treatment in the neoadjuvant, adjuvant or definitive setting for curative intent. Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2
  • Current cancer patient at PeaceHealth (Southwest Medical Center or St. Joes)
  • Not current Medicaid enrollee
  • Not enrolled in hospice
  • Screens positive for financial fragility

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Health services research

Study locations

United States · 2 centers
  • PeaceHealth Saint Joseph Medical Center — Bellingham
  • PeaceHealth Southwest Medical Center — Vancouver

Identifiers

NCT: NCT06771739 · RG1124982 · NCI-2024-10341 · UG1CA189974

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗